This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open” below will launch the full-text article in another browser window.Expression of the activated neu oncogene in transgenic mice has been associated with both the synchronous (single-step) and the stochastic (multistep) transformation of the mammary epithelium. To determine the basis for these conflicting observations, additional strains of transgenic mice carrying the activated neu oncogene under the transcriptional control of the mouse mammary tumor virus promoter/enhancer were produced. Activated neu transgene expression, as measured by in situ hybridization and ribonuclease protection assays, resulted in rapid conversion of the normal mamm...
www.tcrt.org Wnt-1 and Neu collaborate to induce mammary tumors in bitransgenic mice carrying both M...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
We previously showed that a vaccine combining interleukin 12 and allogeneic p185(neu)-positive mamma...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
AbstractTo determine the impact of tumor progression on the reversibility of Neu-induced tumorigenes...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Numerous studies have shown that the overexpression and amplifica-tion of ErbB2/Neu are observed in ...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of three new mouse mammary tumor ce...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
Thirty percent of human breast cancers have amplification of ERBB2, often in conjunction with mutati...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
The Neu (ErbB2, HER2) member of the epidermal growth factor receptor family is implicated in many hu...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
www.tcrt.org Wnt-1 and Neu collaborate to induce mammary tumors in bitransgenic mice carrying both M...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
We previously showed that a vaccine combining interleukin 12 and allogeneic p185(neu)-positive mamma...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
AbstractTo determine the impact of tumor progression on the reversibility of Neu-induced tumorigenes...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Numerous studies have shown that the overexpression and amplifica-tion of ErbB2/Neu are observed in ...
<p><b>Copyright information:</b></p><p>Taken from "Investigation of three new mouse mammary tumor ce...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
Thirty percent of human breast cancers have amplification of ERBB2, often in conjunction with mutati...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
The Neu (ErbB2, HER2) member of the epidermal growth factor receptor family is implicated in many hu...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
www.tcrt.org Wnt-1 and Neu collaborate to induce mammary tumors in bitransgenic mice carrying both M...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
We previously showed that a vaccine combining interleukin 12 and allogeneic p185(neu)-positive mamma...